Diagnostic, Therapeutic, and Clinical Trial Conundrum of Patients With Chronic Kidney Disease
Author:
Funder
Omron Healthcare
National Heart, Lung, and Blood Institute
AstraZeneca
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference12 articles.
1. Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease;Charytan;Circulation,2012
2. Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy;Schmidt;Am J Kidney Dis,2001
3. Clinical features of unrecognized myocardial infarction—silent and symptomatic. Eighteen year follow-up: the Framingham study;Margolis;Am J Cardiol,1973
4. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination;Ohtake;J Am Soc Nephrol,2005
5. The Framingham predictive instrument in chronic kidney disease;Weiner;J Am Coll Cardiol,2007
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Left Main Coronary Artery Revascularization in Patients with Impaired Renal Function: Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting;Kidney and Blood Pressure Research;2023
2. Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease: Chronic Kidney Disease Has an Independent Adverse Effect on the Long-Term Outcome of Coronary Artery Bypass Grafting;BioMed Research International;2022-04-26
3. Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia;American Heart Journal;2022-01
4. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis;Cardiovascular Revascularization Medicine;2019-12
5. Kardiovaskuläre Pharmakotherapie und koronare Revaskularisation bei terminaler Niereninsuffizienz;Herz;2019-08-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3